McKesson Corporation

NYSE: MCK · Real-Time Price · USD
707.78
1.01 (0.14%)
At close: May 02, 2025, 3:59 PM
708.41
0.09%
After-hours: May 02, 2025, 05:34 PM EDT
0.14%
Bid 672.43
Market Cap 88.7B
Revenue (ttm) 344.58B
Net Income (ttm) 2.83B
EPS (ttm) 21.77
PE Ratio (ttm) 32.51
Forward PE 19.17
Analyst Buy
Ask 713
Volume 640,920
Avg. Volume (20D) 1,004,180
Open 712.46
Previous Close 706.77
Day's Range 703.87 - 716.40
52-Week Range 464.42 - 728.32
Beta 0.49

About MCK

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management,...

Sector Healthcare
IPO Date Nov 10, 1994
Employees 45,000
Stock Exchange NYSE
Ticker Symbol MCK
Full Company Profile

Analyst Forecast

According to 14 analyst ratings, the average rating for MCK stock is "Buy." The 12-month stock price forecast is $675, which is a decrease of -4.63% from the latest price.

Stock Forecasts

Next Earnings Release

McKesson Corporation is scheduled to release its earnings on May 8, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-0.55%
McKesson Shares Rise Nearly 1% After Key Signal... Unlock content with Pro Subscription
1 month ago
+3.37%
McKesson shares are trading higher after Mizuho raised its price target on the stock from $630 to $690.